• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱肿瘤中组织浸润淋巴细胞的免疫活性

Immunocompetence of tissue infiltrating lymphocytes in bladder tumors.

作者信息

Tsujihashi H, Matsuda H, Uejima S, Akiyama T, Kurita T

机构信息

Department of Urology, Kinki University School of Medicine, Osaka, Japan.

出版信息

J Urol. 1988 Oct;140(4):890-4. doi: 10.1016/s0022-5347(17)41851-9.

DOI:10.1016/s0022-5347(17)41851-9
PMID:3262173
Abstract

Tissue infiltrating lymphocytes (TIL) in bladder tumors have been assumed to be an expression of local host resistance against the tumor. We investigated the functional activity of TIL compared to peripheral blood lymphocytes (PBL). Isolation of TIL was performed using the enzyme cocktail treatment with Ficoll-Hypaque discontinuous gradient centrifugation. Analysis of lymphocyte subsets by flow cytometry demonstrated Leu 4, 43.6% (T cells); Leu 10, 10.5% (B cells) and Leu 7, 13.1% (natural killer (NK) cells) in TIL. The cytotoxic activity of TIL and PBL was tested in a four hour 51Cr-release assay. Myeloid K562 cells (NK sensitive), HT 1197 (bladder tumor) and fresh bladder tumors were used as target cells. The spontaneous NK cell activity of PBL was 23.7%, whereas that of TIL was only 3.5%. However, in vitro culture with IL2 induced a significant augmentation of NK activity in TIL as well as in PBL. On the other hand, the spontaneous lymphokine activated killer cell (LAK) activity of PBL and TIL was very low. IL2-cultured PBL and TIL exhibited the highest levels of lysis against fresh bladder tumors. Unlike PBL, IL2-induced cytotoxicity of TIL against autologous bladder tumors was higher than that against allogenic bladder tumors. Immunomodulators OK432 and Il2 were injected intratumorally during endoscopy. Analysis of the lymphocyte subsets in TIL showed an increase of T and NK cells following immunomodulator injection. Endoscopic injection of immunomodulators into bladder tumors augmented NK cell functional activity in TIL as well as PBL. These findings suggest that local immunosurveillance is directed against bladder tumors. Further studies are required to understand more fully the local and systemic host immune responses in cancer.

摘要

膀胱肿瘤中的组织浸润淋巴细胞(TIL)被认为是局部宿主对肿瘤抵抗力的一种表现。我们研究了TIL与外周血淋巴细胞(PBL)相比的功能活性。采用酶混合物处理并结合Ficoll-泛影葡胺不连续梯度离心法分离TIL。通过流式细胞术分析淋巴细胞亚群,结果显示TIL中Leu 4阳性细胞占43.6%(T细胞);Leu 10阳性细胞占10.5%(B细胞);Leu 7阳性细胞占13.1%(自然杀伤(NK)细胞)。在4小时的51Cr释放试验中检测了TIL和PBL的细胞毒性活性。髓系K562细胞(NK敏感细胞)、HT 1197细胞(膀胱肿瘤细胞)和新鲜膀胱肿瘤组织用作靶细胞。PBL的自发NK细胞活性为23.7%,而TIL的仅为3.5%。然而,用白细胞介素2(IL2)进行体外培养可显著增强TIL以及PBL中的NK活性。另一方面,PBL和TIL的自发淋巴因子激活杀伤细胞(LAK)活性非常低。经IL2培养的PBL和TIL对新鲜膀胱肿瘤的裂解水平最高。与PBL不同,IL2诱导的TIL对自体膀胱肿瘤的细胞毒性高于对同种异体膀胱肿瘤的细胞毒性。在内镜检查期间将免疫调节剂OK432和IL2瘤内注射。对TIL中的淋巴细胞亚群分析显示,注射免疫调节剂后T细胞和NK细胞增加。向膀胱肿瘤内内镜注射免疫调节剂可增强TIL以及PBL中的NK细胞功能活性。这些发现表明局部免疫监视针对膀胱肿瘤。需要进一步研究以更全面地了解癌症中局部和全身宿主免疫反应。

相似文献

1
Immunocompetence of tissue infiltrating lymphocytes in bladder tumors.膀胱肿瘤中组织浸润淋巴细胞的免疫活性
J Urol. 1988 Oct;140(4):890-4. doi: 10.1016/s0022-5347(17)41851-9.
2
Role of natural killer cells in bladder tumor.
Eur Urol. 1989;16(6):444-9. doi: 10.1159/000471637.
3
Immunoresponse of tissue infiltrating lymphocytes in bladder tumors.膀胱肿瘤中组织浸润淋巴细胞的免疫反应
J Urol. 1989 Jun;141(6):1467-70. doi: 10.1016/s0022-5347(17)41348-6.
4
Activation by the protein-bound polysaccharide PSK (krestin) of cytotoxic lymphocytes that act on fresh autologous tumor cells and T24 human urinary bladder transitional carcinoma cell line in patients with urinary bladder cancer.蛋白结合多糖PSK(云芝多糖K)对膀胱癌患者中作用于新鲜自体肿瘤细胞和T24人膀胱移行癌细胞系的细胞毒性淋巴细胞的激活作用。
J Urol. 1991 May;145(5):1082-7. doi: 10.1016/s0022-5347(17)38539-7.
5
In vitro enhancement of natural killer cell activity by BCG and the antagonistic inhibition of the susceptibility of K562 cells to lysis by peripheral blood lymphocytes in patients with urinary bladder tumor.卡介苗对自然杀伤细胞活性的体外增强作用以及对膀胱肿瘤患者外周血淋巴细胞裂解K562细胞敏感性的拮抗抑制作用。
Int J Urol. 1994 Mar;1(1):49-56. doi: 10.1111/j.1442-2042.1994.tb00008.x.
6
Lysis by interleukin 2-stimulated tumor-infiltrating lymphocytes of autologous and allogeneic tumor target cells.白细胞介素2刺激的肿瘤浸润淋巴细胞对自体和异体肿瘤靶细胞的溶解作用。
Cancer Immunol Immunother. 1989;28(1):67-73. doi: 10.1007/BF00205803.
7
Significance of cytotoxic activity of peripheral blood lymphocytes against autologous tumor cells in patients with bladder cancer.膀胱癌患者外周血淋巴细胞对自体肿瘤细胞的细胞毒性活性的意义。
Cancer Biother Radiopharm. 1996 Dec;11(6):385-91. doi: 10.1089/cbr.1996.11.385.
8
Effects of systemic recombinant interleukin-2 on natural killer and lymphokine activated killer activity of human tumor infiltrating lymphocytes.全身性重组白细胞介素-2对人肿瘤浸润淋巴细胞自然杀伤及淋巴因子激活的杀伤活性的影响
Cancer Res. 1988 Mar 1;48(5):1180-3.
9
Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.淋巴因子激活的杀伤细胞现象。白细胞介素2激活的自体人外周血淋巴细胞对天然杀伤抗性新鲜实体瘤细胞的杀伤作用。
J Exp Med. 1982 Jun 1;155(6):1823-41. doi: 10.1084/jem.155.6.1823.
10
Adriamycin-mediated potentiation of cytotoxicity against freshly isolated bladder cancer cells by autologous non-activated peripheral blood lymphocytes and tumor infiltrating lymphocytes.阿霉素介导的自体未激活外周血淋巴细胞和肿瘤浸润淋巴细胞对新鲜分离的膀胱癌细胞细胞毒性的增强作用。
J Urol. 1999 Dec;162(6):2170-5. doi: 10.1016/S0022-5347(05)68154-2.

引用本文的文献

1
PD-1 and PD-L1 are more highly expressed in high-grade bladder cancer than in low-grade cases: PD-L1 might function as a mediator of stage progression in bladder cancer.与低级别膀胱癌相比,程序性死亡受体1(PD-1)和程序性死亡配体1(PD-L1)在高级别膀胱癌中表达更高:PD-L1可能是膀胱癌分期进展的一个介质。
BMC Urol. 2018 Nov 6;18(1):97. doi: 10.1186/s12894-018-0414-8.
2
Novel immunotherapy approaches for metastatic urothelial and renal cell carcinoma.转移性尿路上皮癌和肾细胞癌的新型免疫治疗方法。
Asian J Urol. 2016 Oct;3(4):268-277. doi: 10.1016/j.ajur.2016.08.013. Epub 2016 Sep 6.
3
Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti-PD-L1 Immune Checkpoint Inhibitor.
阿维鲁单抗(一种抗 PD-L1 免疫检查点抑制剂)治疗非肌肉浸润性膀胱癌的系统免疫治疗。
Cancer Immunol Res. 2016 May;4(5):452-62. doi: 10.1158/2326-6066.CIR-15-0176. Epub 2016 Feb 26.
4
Immunotherapies for bladder cancer: a new hope.膀胱癌的免疫疗法:新希望
Curr Opin Urol. 2015 Nov;25(6):586-96. doi: 10.1097/MOU.0000000000000213.
5
An essential role for decorin in bladder cancer invasiveness.核心聚糖在膀胱癌侵袭性中的重要作用。
EMBO Mol Med. 2013 Dec;5(12):1835-51. doi: 10.1002/emmm.201302655. Epub 2013 Oct 20.
6
The type of lymphocyte infiltration near urothelial carcinoma is diagnostic for chronic lymphocytic leukemia.尿路上皮癌附近的淋巴细胞浸润类型对慢性淋巴细胞白血病具有诊断意义。
Urol Ann. 2013 Jan;5(1):47-9. doi: 10.4103/0974-7796.106968.
7
The effects of chemotherapeutic drugs on human monocyte-derived dendritic cell differentiation and antigen presentation.化疗药物对人源单核细胞来源树突状细胞分化和抗原呈递的影响。
Clin Exp Immunol. 2013 Jun;172(3):490-9. doi: 10.1111/cei.12060.
8
The association between the recurrence of solitary non-muscle invasive bladder cancer and tumor infiltrating lymphocytes.孤立性非肌层浸润性膀胱癌复发与肿瘤浸润淋巴细胞之间的关联
Croat Med J. 2012 Dec;53(6):598-604. doi: 10.3325/cmj.2012.53.598.
9
Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer.聚焦肿瘤浸润淋巴细胞:肿瘤浸润淋巴细胞在人类膀胱癌中的预后意义
Cancer Immun. 2007 Jun 26;7:10.
10
Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers.B7-H1(程序性死亡受体配体1)的过表达与人类尿路上皮癌的肿瘤分级及术后预后显著相关。
Cancer Immunol Immunother. 2007 Aug;56(8):1173-82. doi: 10.1007/s00262-006-0266-z. Epub 2006 Dec 22.